- Latest available (Revised)
- Original (As made)
The Cosmetic Products (Safety) Regulations 2008
You are here:
What Version
Status:
This is the original version (as it was originally made).
PART 1List of permitted UV filters which cosmetic products contain
For the purposes of this Regulation, UV filters are substances which, contained in cosmetic sun-screen products, are specifically intended to filter certain UV rays in order to protect the skin from certain harmful effects of these rays.
The UV filters may be added to other cosmetic products within the limits and under the conditions laid down in this Schedule.
Other UV filters used in cosmetic products solely for the purpose of protecting the product against UV rays are not included in this list.
| Reference No | Substances | Maximum authorised concentration | Other limitations and requirements | Conditions of use and warnings which must be printed on the label |
|---|---|---|---|---|
| a | b | c | d | e |
(1) Not required if concentration is 0.5% or less and when it is used only for product protection purposes. | ||||
| 1 | 4-Aminobenzoic acid | 5.0% | ||
| 2 | N,N,N-Trimethyl-4-(2-oxoborn-3-ylidenemethyl) anilinium methyl sulphate | 6.0% | ||
| 3 | Homosalate (INN) | 10% | ||
| 4 | Oxybenzone (INN) | 10% | Contains oxybenzone(1) | |
| 5 | [omitted] | |||
| 6 | 2-phenylbenzimidazole-5-sulfonic acid and its potassium, sodium and triethanolamine salts | 8% (expressed as acid) | ||
| 7 | 3,3’-(1,4-Phenylenedimethylene) bis (7, 7-dimethyl-2-oxobicyclo-[2,2,1]hept-1-ylmethanesulfonic acid) and its salts | 10% (expressed as acid) | ||
| 8 | 1-(4-tert-butylphenyl)-3-(4-methoxyphenyl) propane-1,3-dione | 5% | ||
| 9 | alpha-(2-Oxoborn-3-ylidene)-toluene-4-sulfonic acid and its salts | 6% (expressed as acid) | ||
| 10 | 2-cyano-3,3-diphenyl acrylic acid, 2-ethylhexyl ester (Octocrylene) | 10% (expressed as acid) | ||
| 11 | Polymer of N-{(2 and 4)-[(2-oxoborn-3-ylidene)methyl]-benzyl}acrylamide | 6% | ||
| 12 | Octyl methoxycinnamate | 10% | ||
| 13 | Ethoxylated Ethyl-4-Aminobenzoate (PEG-25 PABA) | 10% | ||
| 14 | Isopentyl-4-methoxycinnamate (Isoamyl p-Methoxycinnamate) | 10% | ||
| 15 | 2,4,6-Trianilino-(p-Carbo-2’-Ethylhexyl-1’Oxy)-1,3,5-Triazine (Octyl Triazone) | 5% | ||
| 16 | Phenol,2-(2H-Benzotriazol-2-yl)-4-Methyl-6-(2-Methyl-3-(1,3,3,3-Tetramethyl-I-(Trimethylsilyl)Oxy)-Disiloxanyl)Propyl) (Drometrizole Trisiloxane) | 15% | ||
| 17 | Benzoic acid, 4,4-((6-(((1,1-dimethylethyl)amino)car-bonyl)phenyl)amino)1,3,5-triazine-2,4-diyl)diimino)bis-, bis-(2-ethylhexyl)ester) | 10% | ||
| 18 | 3-(4’-Methylbenxylidene)-d-1 camphor(4-Methylbenzylidene Camphor) | 4% | ||
| 19 | 3-Benzylidene camphor (3-Benzylidene Camphor) | 2% | ||
| 20 | 2-Ethylhexyl salicylate (Octyl-salicylate) | 5% | ||
| 21 | 4-Dimethyl-amino-benzoate of ethyl-2-hexyl (octyl dimethyl PABA) | 8% | ||
| 22 | 2-Hydroxy-4-methoxybenzophenone-5-sulfonic acid (Benzophenone-5) and its sodium salt | 5% (expressed as acid) | ||
| 23 | 2,2’-Methylene-bis-6-(2H-benzotriazol-2yl)-4-(tetramethyl-butyl)-1,1,3,3-phenol | 10% | ||
| 24 | Monosodium salt of 2-2’-bis-(1,4-phenylene) 1H-benzimidazole-4,6-disulphonic acid) | 10% (expressed as acid) | ||
| 25 | (1,3,5)-Triazine-2,4-bis((4-(2-ethyl-hexyloxy)-2-hydroxy)-phenyl)-6-(4-methoxyphenyl) | 10% | ||
| 26 | Dimethicodiethylbenzal-malonate (CAS No 207574-74-1) | 10% | ||
| 27 | Titanium dioxide | 25% | ||
| 28 | Benzoic acid, 2-[-4-(diethylamino)-2-hydroxybenzoyl]-, hexylester (INCI name: Diethylamino Hydroxybenzoyl Hexyl Benzoate; CAS No 302776-68-7) | 10% in sunscreen products | ||
Options/Help
Print Options
PrintThe Whole Instrument
PrintThe Whole Schedule
PrintThis Part only
Legislation is available in different versions:
Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.
Original (As Enacted or Made): The original version of the legislation as it stood when it was enacted or made. No changes have been applied to the text.
Opening Options
Different options to open legislation in order to view more content on screen at once
Explanatory Memorandum
Explanatory Memorandum sets out a brief statement of the purpose of a Statutory Instrument and provides information about its policy objective and policy implications. They aim to make the Statutory Instrument accessible to readers who are not legally qualified and accompany any Statutory Instrument or Draft Statutory Instrument laid before Parliament from June 2004 onwards.
More Resources
Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:
- the original print PDF of the as enacted version that was used for the print copy
- lists of changes made by and/or affecting this legislation item
- confers power and blanket amendment details
- all formats of all associated documents
- correction slips
- links to related legislation and further information resources
More Resources
Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include:
- the original print PDF of the as made version that was used for the print copy
- correction slips
Click 'View More' or select 'More Resources' tab for additional information including:
- lists of changes made by and/or affecting this legislation item
- confers power and blanket amendment details
- all formats of all associated documents
- links to related legislation and further information resources
All content is available under the Open Government Licence v3.0 except where otherwise stated. This site additionally contains content derived from EUR-Lex, reused under the terms of the Commission Decision 2011/833/EU on the reuse of documents from the EU institutions. For more information see the EUR-Lex public statement on re-use.